---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-050405"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:53:27.957071+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma raises $2M in registered direct offering with warrants

## Summary
- Sold 917,432 shares at $2.18/share and issued warrants for 917,432 shares at $2.06 exercise price.
- Gross proceeds ~$2M; net proceeds for working capital and general corporate purposes.
- H.C. Wainwright acted as exclusive placement agent; fees include 7.5% cash fee and 68,807 warrant shares.
- Closing occurred June 6, 2024; warrants exercisable immediately for 5 years.
- Officers and directors subject to 15-day lock-up; company restricted from variable-rate transactions for one year.

## SEC filing metadata
- accession: 0001213900-24-050405
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390024050405/0001213900-24-050405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390024050405/ea0207381-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-050405
- JSON: https://secwatch.observer/filing/0001213900-24-050405.json
- Plain text: https://secwatch.observer/filing/0001213900-24-050405.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.